Evidence map›Paper›PMID 27379439›Full record

ReviewCurrent opinion in obstetrics & gynecology2016

The urinary microbiota: a paradigm shift for bladder disorders?

Linda Brubaker, Alan Wolfe

Abstract readReview
In one paragraph

Review in Current opinion in obstetrics & gynecology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. The Urinary Microbiome and Bladder Cancer.Life (Basel, Switzerland) · 2023
    Review
  11. Clinical relevance of expanded quantitative urine culture in health and disease.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. The human urobiome.Mammalian genome : official journal of the International Mammalian Genome Society · 2021
    Review
  18. Local induction of bladder Th1 responses to combat urinary tract infections.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Modeling of Urinary Microbiota Associated With Cystitis.Frontiers in cellular and infection microbiology · 2021
    Article
  20. A highly polarized TNature immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Linda BrubakeraDepartments of Obstetrics & Gynecology and Urology, Stritch School of Medicine bDepartment of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.
Alan Wolfe
Loyola University Chicago · US

Funding

Urinary Incontinence Treatment Network: DCCU01DK058229 · NIDDK · NEW ENGLAND RESEARCH INSTITUTES, INC. · PI TENNSTEDT, SHARON L · 2000 to 2012
$16.1M
The Pelvic Floor Disorders NetworkU10HD041250 · NICHD · LOYOLA UNIVERSITY CHICAGO · PI BRUBAKER, LINDA · 2001 to 2015
$3.8M
The Female Urinary Microbiome and Urinary IncontinenceR01DK104718 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI BRUBAKER, LINDA, WOLFE, ALAN J · 2016 to 2020
$3.1M
The Female Urinary Microbiome: Adjacent Microbiomes and Clinical AssociationsP20DK108268 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI WOLFE, ALAN J · 2015 to 2016
$583k
Urinary Bacterial Communities in Urge Incontinence WomenR21DK097435 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI BRUBAKER, LINDA, GAI, XIAOWU · 2013 to 2014
$414k
The Female Urinary Microbiome and Urinary IncontinenceR56DK104718 · NIDDK · LOYOLA UNIVERSITY CHICAGO · PI BRUBAKER, LINDA, WOLFE, ALAN J · 2015 to 2015
$300k
NICHD NIH HHS U10 HD041250NIDDK NIH HHS P20 DK108268NIDDK NIH HHS R01 DK104718NIDDK NIH HHS R21 DK097435NIDDK NIH HHS R56 DK104718NIDDK NIH HHS U01 DK058229
6 · The paper itself

Abstract

purpose of reviewA resident microbial community [the female urinary microbiota (FUM)] exists within the female bladder of many adult women. Information about the FUM is likely to modify the diagnosis, prevention and treatment of adult women with urinary disorders. This review highlights key findings from recent literature relevant to adult, nonpregnant women. RECENT

findingsSimilar to other human microbial communities, the FUM varies in its characteristics, including organism diversity and predominant organism identity. Recent literature reveals previously undetected organisms and community characteristics that appear associated with certain urinary symptoms, including urinary tract infection and urgency urinary incontinence. The role of individual organisms may range from beneficial to pathogenic and may vary on the basis of an individual's FUM characteristics. The simple dichotomy of 'infected' or 'sterile' no longer sufficiently captures the microbiological complexity of the female bladder. SUMMARY: Deeper understanding of the FUM should yield better methods to restore the microbiota to a healthy state, providing symptom relief. Opportunities to modify the FUM without antibiotic use are exciting possibilities for future research; stand-alone antibiotic use may be reevaluated to improve treatment precision. Long-standing nomenclature for conditions such as asymptomatic bacteriuria and urinary tract infection will likely require modification.

Indexed as

MicrobiotaAnti-Bacterial AgentsFemaleHumansTreatment OutcomeUrinalysisUrinary BladderUrinary IncontinenceUrinary TractUrinary Tract InfectionsAnti-Bacterial Agents

Identifiers

PMID27379439
PMCPMC5378062
OpenAlexW2470127204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.